Fertility Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Drug ( Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment, Gonadotrophins, Aromatase Inhibitors, Estrogen Receptor Modulators, Dopamine Agonists, Metformin Hydrochloride, Others. ); Procedure ( Assisted Reproductive Technology, Artificial Insemination, Hysteroscopy, Laparoscopy And Robotic Laparoscopy, Laparotomy/Open Surgery, Egg Retrieval, Varicocelectomy, Vasectomy Reversal (Vasovasostomy Or Vasoepididymostomy), Sperm Retrieval (Epididymal Aspiration) ); End User ( Fertility Clinics, Hospitals, Clinical Research Institutes, Others )
Report Code: TIPRE00012510 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Fertility treatment refers to treatment options used to stimulate the production of egg or sperm and includes procedures that handle eggs, sperm, or embryos. Fertility drugs are used to treat Ovulation disorders which accounts for 25% of female infertility cases. Fertility drugs stimulate ovulation in females thus promoting fertility. The most common fertility drugs include Clomid, Femara, and gonadotropins. Assisted reproductive technologies (ART) includes fertility treatments that involve Assisted reproductive technologies (ART) refer to fertility treatments that involve the handling of eggs or embryos. GIFT (gamete intrafallopian transfer), ZIFT (zygote intrafallopian transfer) and others.
MARKET DYNAMICS
The fertility treatment market is driving due to the rise in awareness about fertility drugs, development of effective treatments, and rising infertility cases. However, high cost of fertility treatments are expected to hamper the growth of the global fertility treatment market.
MARKET SCOPE
The "Fertility Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of fertility treatment market with detailed market segmentation by drug, procedure and end user. The fertility treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in fertility treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The fertility treatment market is segmented on the basis of drug, procedure and end user. Based on drug, the market is segmented as clomiphene citrate, letrozole, serophene, hormone treatment, gonadotrophins, aromatase inhibitors, estrogen receptor modulators, dopamine agonists, metformin hydrochloride, and others. On the basis of procedure, the market is categorized as assisted reproductive technology, artificial insemination, hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration). On the basis of end user, the market is categorized as fertility clinics, hospitals, clinical research institutes, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the fertility treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fertility treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting fertility treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the fertility treatment market in these regions.
The report covers key developments in the fertility treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from fertility treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the fertility treatment market.
The report also includes the profiles of key players in fertility treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Fertility treatment refers to treatment options used to stimulate the production of egg or sperm and includes procedures that handle eggs, sperm, or embryos. Fertility drugs are used to treat Ovulation disorders which accounts for 25% of female infertility cases. Fertility drugs stimulate ovulation in females thus promoting fertility. The most common fertility drugs include Clomid, Femara, and gonadotropins. Assisted reproductive technologies (ART) includes fertility treatments that involve Assisted reproductive technologies (ART) refer to fertility treatments that involve the handling of eggs or embryos. GIFT (gamete intrafallopian transfer), ZIFT (zygote intrafallopian transfer) and others.
MARKET DYNAMICS
The fertility treatment market is driving due to the rise in awareness about fertility drugs, development of effective treatments, and rising infertility cases. However, high cost of fertility treatments are expected to hamper the growth of the global fertility treatment market.
MARKET SCOPE
The "Fertility Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of fertility treatment market with detailed market segmentation by drug, procedure and end user. The fertility treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in fertility treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The fertility treatment market is segmented on the basis of drug, procedure and end user. Based on drug, the market is segmented as clomiphene citrate, letrozole, serophene, hormone treatment, gonadotrophins, aromatase inhibitors, estrogen receptor modulators, dopamine agonists, metformin hydrochloride, and others. On the basis of procedure, the market is categorized as assisted reproductive technology, artificial insemination, hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration). On the basis of end user, the market is categorized as fertility clinics, hospitals, clinical research institutes, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the fertility treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fertility treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting fertility treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the fertility treatment market in these regions.
The report covers key developments in the fertility treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from fertility treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the fertility treatment market.
The report also includes the profiles of key players in fertility treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck & Co. Pharmaceutical Company
- Noven Pharmaceutical Inc.
- Janssen Pharmaceuticals Inc.
- Personal Products Company
- Pfizer Inc.
- Eli Lilly
- Baxter Healthcare Corporation
- Ferring Pharmaceuticals Inc.
- Procter & Gamble Pharmaceuticals
- Emd Serono Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Merck & Co. Pharmaceutical Company
2. Noven Pharmaceutical Inc.
3. Janssen Pharmaceuticals Inc.
4. Personal Products Company
5. Pfizer Inc.
6. Eli Lilly
7. Baxter Healthcare Corporation
8. Ferring Pharmaceuticals Inc.
9. Procter & Gamble Pharmaceuticals
10. Emd Serono Inc.
1. Merck & Co. Pharmaceutical Company
2. Noven Pharmaceutical Inc.
3. Janssen Pharmaceuticals Inc.
4. Personal Products Company
5. Pfizer Inc.
6. Eli Lilly
7. Baxter Healthcare Corporation
8. Ferring Pharmaceuticals Inc.
9. Procter & Gamble Pharmaceuticals
10. Emd Serono Inc.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount